Risk of ticagrelor versus clopidogrel discontinuation. Response
Revista Española de Cardiología (English Edition) · 2024
DOI: 10.1016/j.rec.2023.11.015 ↗Kurz gefasst
Leserbrief in der Zeitschrift Revista Española de Cardiología (English Edition), 2024. Verfasst von Manuel Almendro-Delia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Agudos Cardiovascular, Hospital Universitario Virgen Macarena, Seville, Spain. Electronic address: trocor@gmail.com. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Percutaneous Coronary Intervention. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Unidad de Agudos Cardiovascular, Hospital Universitario Virgen Macarena, Seville, Spain. Electronic address: trocor@gmail.com.
- Unidad de Agudos Cardiovascular, Hospital Universitario Virgen Macarena, Seville, Spain.
Zitieren
APA
Almendro-Delia, M., García-Rubira, J. C., & Hidalgo-Urbano, R. (2024). Risk of ticagrelor versus clopidogrel discontinuation. Response. Revista Española de Cardiología (English Edition). https://doi.org/10.1016/j.rec.2023.11.015
Vancouver
Almendro-Delia M, García-Rubira JC, Hidalgo-Urbano R. Risk of ticagrelor versus clopidogrel discontinuation. Response. Revista Española de Cardiología (English Edition). 2024. doi:10.1016/j.rec.2023.11.015
BibTeX
@article{AlmendroDelia2024,
author = {Almendro-Delia, Manuel and García-Rubira, Juan C and Hidalgo-Urbano, Rafael},
title = {Risk of ticagrelor versus clopidogrel discontinuation. Response},
journal = {Revista Española de Cardiología (English Edition)},
year = {2024},
doi = {10.1016/j.rec.2023.11.015}
}
EUVIMED